New implant aims to simplify dialysis fistula monitoring

NCT ID NCT04896476

First seen Jun 02, 2026 · Last updated Jun 19, 2026 · Updated 3 times

Summary

This study tested a new device called EchoMark LP, which is implanted near a surgically created blood vessel connection (fistula) used for dialysis. The device works with a special ultrasound system (EchoSure) to measure blood flow, depth, and diameter of the fistula. The trial involved 20 adults with kidney disease who needed a fistula, and its main goal was to see if the implant is safe and if the measurements can be taken successfully.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS FISTULA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Michgan Vascular Center

    Flint, Michigan, 48507, United States

  • SKI Vascular Center

    Peoria, Arizona, 85381, United States

  • Surgical Specialist of Charlotte

    Charlotte, North Carolina, 28207, United States

  • Trinity Research Group

    Dothan, Alabama, 36301, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

EchoMark LP implant and EchoSure diagnostic ultrasound system

What this could lead to

If successful, this device could make it easier and safer to monitor arteriovenous fistulas in dialysis patients, potentially reducing complications.

What could go wrong

This is a very small, early feasibility study with only 20 participants. It is designed to test safety and basic function, not to prove the device improves health outcomes.

Conditions

The condition(s) this trial relates to.

Arteriovenous Fistula end stage renal failure Kidney Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.